Latest Merz Pharma Stories
FRANKFURT, Germany, April 8, 2013 /PRNewswire/ -- Merz Pharma Group ("Merz" or "the Company") today announced that it has withdrawn its non-binding proposal to acquire all of the outstanding common stock of Obagi Medical Products, Inc. (NASDAQ-GS: OMPI) ("Obagi") for $22 per share in cash. The decision to withdraw the proposal follows the recent announcement that Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") increased its offer to acquire Obagi from...
GREENSBORO, N.C., Feb. 21, 2013 /PRNewswire/ -- Mederma(®) today announced the results of the second Mederma(®) Wear Your Skin Proudly(TM) survey, conducted by Harris Interactive, which revealed men and women have very different views when it comes to skin imperfections and their impact on self-confidence. The survey found that most U.S. men and women aged 18 and older (67 percent) are generally happy with their physical appearance; however, 44 percent of women felt that improving...
GREENSBORO, N.C., Nov. 6, 2012 /PRNewswire/ -- Merz, Inc. through its aesthetics division, Merz Aesthetics, Inc., today announced the nationwide availability of BELOTERO BALANCE® Dermal Filler, a natural-looking, long-lasting dermal filler that was approved by the Food and Drug Administration (FDA) in November 2011 as a safe solution for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds, or smile lines around the mouth. This dermal filler...
GREENSBORO, N.C., Nov. 1, 2012 /PRNewswire/ -- Merz, Inc., through its aesthetics division Merz Aesthetics, Inc., the exclusive distributor of Asclera(®) (polidocanol) Injection in the U.S., today announces the beginning of the STAND AND DELIVER program. STAND AND DELIVER was originally launched in 2011 to celebrate inspirational women who are making positive contributions to their communities. After a highly successful first year, Merz Inc. has decided to continue its dedication...
GREENSBORO, N.C., Oct. 1, 2012 /PRNewswire/ -- Merz, Inc. (US affiliate of Merz Pharma Group) today announced that Hyunna Coelho has been promoted to vice president, commercial excellence. As Vice President - Commercial Excellence, Coelho will be primarily responsible for commercial excellence in the areas of sales training and development, corporate communication, sales operations, market research, competitive intelligence, forecasting, and operational analytics for Merz in the...
GREENSBORO, N.C., Sept. 17, 2012 /PRNewswire/ -- Merz, Inc. (U.S. affiliate of Merz Pharma Group) today announced the appointment of Cynthia Schwalm has as vice president, neurology effective immediately. Schwalm will be responsible for the Merz's growing neurology business unit in the U.S., which includes the recently acquired product CUVPOSA(®). "Cynthia brings national as well as international experience, in developing and commercializing pharmaceutical products. We are extremely...
GREENSBORO, N.C., July 9, 2012 /PRNewswire/ -- Merz, Inc. (US affiliate of Merz Pharma Group) today announced that Katrina Church has been promoted to vice president, chief compliance officer, effective July 1, 2012. Church will be responsible for providing strategic and operational leadership relating to compliance issues. "Katrina brings extensive experience and a wealth of legal knowledge in pharmaceutical regulatory compliance to her new role," said Bill Humphries, president and...
SAN MATEO, Calif., May 24, 2012 /PRNewswire/ -- Today, Merz Aesthetics, Inc., the exclusive distributor of Asclera® (polidocanol) Injection in the U.S., announces Michelle Rubin as the grand prize winner of the "STAND AND DELIVER" program, an initiative created to honor women who take a stand and make a difference in their communities. Michelle Rubin, founder and director of Autism After 21, a nonprofit 501(c) organization which provides opportunities and services for autistic...
FRANKFURT, Germany, Nov. 17, 2011 /PRNewswire/ -- Merz Pharmaceuticals today announced that results from five studies examining XEOMIN® (incobotulinumtoxinA), a botulinum neurotoxin type A preparation free from accessory proteins, will be presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) in Orlando, Fla. The first poster being presented at the meeting, titled "Sustained efficacy of incobotulinumtoxinA (XEOMIN®; botulinum...
SAN MATEO, Calif., Nov. 16, 2011 /PRNewswire/ -- Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved BELOTERO Balance® for the correction of moderate-to-severe facial wrinkles and folds. BELOTERO Balance® filler is a hyaluronic acid-based cohesive gel dermal filler designed to deliver natural-looking results with little recovery time. BELOTERO® filler is currently approved for aesthetic use in the United Kingdom, Germany,...
